Tag
#EVT
-
2026
-
Evotec Appoints Dr. Ashiq H. Khan as Chief Commercial Officer
-
Evotec SE to Announce Fourth Quarter and Full-Year 2025 Results on April 8, 2026
-
Just – Evotec Biologics Enters Project Agreement with BARDA to Optimize Biomanufacturing of Antibodies Against Ebola and Related Viruses
-
Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation
-
Economic Investment Trust Limited Announces Renewal of Normal Course Issuer Bid
-
Eaton Vance Closed-End Funds Release Estimated Sources of Distributions